secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001688757-24-000042
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA schedules PMA preapproval inspection of Establishment Labs' Motiva Implants facility in Q2 2024
--------------------------------------------------------------------------------

- FDA schedules PMA preapproval inspection of Motiva Implants manufacturing facility for Q2 2024.
- Inspection is a required step in the premarket approval (PMA) process for U.S. market entry.
- Announcement made on April 2, 2024 during J.P. Morgan MedTech CEO Conference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000168875724000042/0001688757-24-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000168875724000042/esta-20240402.htm
  HTML page:      https://secwatch.observer/filing/0001688757-24-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer